Impact of Baseline Body Mass Index on the Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis

Ritchlin, C, Ogdie, A, Giles, J et al. (9 more authors) (2019) Impact of Baseline Body Mass Index on the Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Metadata

Authors/Creators:
  • Ritchlin, C
  • Ogdie, A
  • Giles, J
  • Gomez-Reino, J
  • Helliwell, P
  • Stockert, L
  • Young, P
  • Joseph, W
  • Mundayat, R
  • Graham, D
  • Woolcott, J
  • Romero, A
Keywords: psoriatic arthritis and body mass, Tofacitinib
Dates:
  • Published: October 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 12 Aug 2020 13:42
Last Modified: 13 Aug 2020 15:10
Status: Published
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)